Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors

References

• Zaia JA. Cytomegalovirus Infection. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG. Thomas’ Hematopoietic Cell Transplantation, 4th edition, Wiley-Blackwell, West Sussex, UK, 2008;1367–1381.
   Google Scholar
• George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, . Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis. 2010;12(4):322–9.
   PubMedGoogle Scholar
• Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, . Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30:425–37.
   PubMed Web of Science ®Google Scholar
• Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Haematologica. 2008;93:248–56.
   PubMed Web of Science ®Google Scholar
• Pourgheysari B, Piper KP, McLarnon A, Arrazi J, Bruton R, Clark F, . Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplant. 2009;43:853–61.
   PubMed Web of Science ®Google Scholar
• Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, . Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation. J Virol. 2008;82:10143–52.
   PubMedGoogle Scholar
• Zhou W, Longmate J, Lacey SF, Palmer JM, Gallez-Hawkins G, Thao L, . Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients. Blood. 2009; 113:6465–76.
   PubMed Web of Science ®Google Scholar
• Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, . Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry B Clin Cytom. 2008;74:211–20.
   PubMedGoogle Scholar
• Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, . Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood. 2002;100:3690–7.
   PubMed Web of Science ®Google Scholar
• Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, . Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49–57.
   PubMedGoogle Scholar
• Widmann T, Sester U, Gartner BC, Schubert J, Pfreundschuh M, Kohler H, . Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS One. 2008;3:e3634.
   Web of Science ®Google Scholar
• Barron MA, Gao D, Springer KL, Patterson JA, Brunvand MW, McSweeney PA, . Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2009;49:1777–83.
   PubMed Web of Science ®Google Scholar
• Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood. 2006;108:1406–12.
   PubMed Web of Science ®Google Scholar
• Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Camara R, . Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2010;45:543–9.
   PubMedGoogle Scholar
• Avetisyan G, Larsson K, Aschan J, Nilsson C, Hassan M, Ljungman P. Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;38:687–92.
   PubMedGoogle Scholar
• Scheinberg P, Melenhorst JJ, Brenchley JM, Hill BJ, Hensel NF, Chattopadhyay PK, . The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. Blood. 2009;114:5071–80.
   PubMed Web of Science ®Google Scholar
• Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, . Recovery of CMV-specific CD8(+) T cells and T regs after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011 Apr;17(4):550–7 (It was ePublished in 2010).
   PubMedGoogle Scholar
• Morita-Hoshi Y, Heike Y, Kawakami M, Sugita T, Miura O, Kim SW, . Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:515–21.
   PubMedGoogle Scholar
• Foster AE, Gottlieb DJ, Sartor M, Hertzberg MS, Bradstock KF. Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2002;8:501–11.
   PubMedGoogle Scholar
• Boeckh M. Changing patterns in the risk of cytomegalovirus disease and treatment-related outcomes in the era of preemptive antiviral therapy. Bone Marrow Transplant. 2006;37(Suppl 1):S31.
   Google Scholar
• Salzberger B, Bowden RA, Hackman RC, Davis C, Boeckh M. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome. Blood. 1997;90:2502–8.
   PubMed Web of Science ®Google Scholar
• Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, . Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991;325:1601–7.
   PubMed Web of Science ®Google Scholar
• Verkruyse LA, Storch GA, Devine SM, Dipersio JF, Vij R. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant. 2006;37:51–6.
   PubMed Web of Science ®Google Scholar
• Lilleri D, Gerna G, Furione M, Bernardo ME, Giorgiani G, Telli S, . Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. Blood. 2007;110:2757–60.
   PubMed Web of Science ®Google Scholar
• Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol. 2005;174:1037–45.
   PubMed Web of Science ®Google Scholar
• Gasser O, Bihl F, Sanghavi S, Rinaldo C, Rowe D, Hess C, . Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant. 2009;9:794–803.
   PubMedGoogle Scholar
• Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, Whittle HC, . Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol. 2008;38:350–63.
   PubMed Web of Science ®Google Scholar
• Choi SM, Lee DG, Choi JH, Yoo JH, Kim YJ, Park SH, . Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea. Int J Hematol. 2006;83:277–8.
   PubMedGoogle Scholar
• Avetisyan G, Aschan J, Hagglund H, Ringden O, Ljungman P. Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant. 2007;40:865–9.
   PubMedGoogle Scholar
• Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, . Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant. 2007;13:299–306.
   PubMed Web of Science ®Google Scholar
• Russell JA, Savoie ML, Balogh A, Turner AR, Larratt L, Chaudhry MA, . Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant. 2007;13:814–21.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, . 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–8.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.
   PubMed Web of Science ®Google Scholar
• Pang XL, Chui L, Fenton J, LeBlanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol. 2003;41:3167–74.
   PubMedGoogle Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094–7.
   PubMed Web of Science ®Google Scholar
• Ugarte-Torres A, Hoegh-Petersen M, Liu Y, Zhou F, Williamson TS, Quinlan D, . Donor serostatus impacts cytomegalovirus-specific immunity, cytomegaloviral disease incidence and survival in seropositive hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2011;46(8):1104–12.
   Google Scholar
• Zelini P, Lilleri D, Comolli G, Rognoni V, Chiesa A, Fornara C, . Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. Clin Immunol. 2010;136:269–81.
   PubMedGoogle Scholar
• Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM, . Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood. 2010;116:4360–7.
   PubMed Web of Science ®Google Scholar
• Micklethwaite KP, Clancy L, Sandher U, Hansen AM, Blyth E, Antonenas V, . Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation. Blood. 2008;112:3974–81.
   PubMed Web of Science ®Google Scholar
• Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol. 1994;68:8056–63.
   PubMed Web of Science ®Google Scholar
• Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, . Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038–44.
   PubMed Web of Science ®Google Scholar
• Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, . Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16:1309–14.
   PubMed Web of Science ®Google Scholar
• Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, . Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood. 2003;102:3060–7.
   PubMed Web of Science ®Google Scholar
• Liberman AC, Druker J, Refojo D, Holsboer F, Arzt E. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J. 2009;23:1558–71.
   Web of Science ®Google Scholar
• Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S, . The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. 2010;116:2164–72.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hieber M, Schwarck S, Stroux A, Ganepola S, Reinke P, Thiel E, . Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion. Int J Hematol. 2010;91:877–85.
   PubMed Web of Science ®Google Scholar
• Chen C, Busson M, Rocha V, Appert ML, Lepage V, Dulphy N, . Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant. 2006;38:437–44.
   PubMed Web of Science ®Google Scholar
• Cook M, Briggs D, Craddock C, Mahendra P, Milligan D, Fegan C, . Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood. 2006;107:1230–2.
   PubMed Web of Science ®Google Scholar
• Zaia JA, Sun JY, Gallez-Hawkins GM, Thao L, Oki A, Lacey SF, . The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15:315–25.
   PubMed Web of Science ®Google Scholar